S&P 500   4,291.03 (+0.20%)
DOW   33,764.31 (+0.00%)
QQQ   356.11 (+0.41%)
AAPL   183.28 (+1.29%)
MSFT   335.54 (+0.04%)
META   271.50 (-0.41%)
GOOGL   126.07 (+1.12%)
AMZN   124.27 (+0.02%)
TSLA   219.33 (+2.51%)
NVDA   391.00 (-0.58%)
NIO   7.73 (+2.25%)
BABA   83.89 (-0.45%)
AMD   117.84 (-0.02%)
T   15.32 (+0.72%)
F   12.59 (+1.61%)
MU   68.81 (-0.52%)
CGC   0.82 (-0.62%)
GE   104.97 (-0.78%)
DIS   90.33 (-0.48%)
AMC   4.63 (+1.76%)
PFE   38.60 (+0.63%)
PYPL   64.37 (+0.64%)
NFLX   404.29 (+0.95%)
S&P 500   4,291.03 (+0.20%)
DOW   33,764.31 (+0.00%)
QQQ   356.11 (+0.41%)
AAPL   183.28 (+1.29%)
MSFT   335.54 (+0.04%)
META   271.50 (-0.41%)
GOOGL   126.07 (+1.12%)
AMZN   124.27 (+0.02%)
TSLA   219.33 (+2.51%)
NVDA   391.00 (-0.58%)
NIO   7.73 (+2.25%)
BABA   83.89 (-0.45%)
AMD   117.84 (-0.02%)
T   15.32 (+0.72%)
F   12.59 (+1.61%)
MU   68.81 (-0.52%)
CGC   0.82 (-0.62%)
GE   104.97 (-0.78%)
DIS   90.33 (-0.48%)
AMC   4.63 (+1.76%)
PFE   38.60 (+0.63%)
PYPL   64.37 (+0.64%)
NFLX   404.29 (+0.95%)
S&P 500   4,291.03 (+0.20%)
DOW   33,764.31 (+0.00%)
QQQ   356.11 (+0.41%)
AAPL   183.28 (+1.29%)
MSFT   335.54 (+0.04%)
META   271.50 (-0.41%)
GOOGL   126.07 (+1.12%)
AMZN   124.27 (+0.02%)
TSLA   219.33 (+2.51%)
NVDA   391.00 (-0.58%)
NIO   7.73 (+2.25%)
BABA   83.89 (-0.45%)
AMD   117.84 (-0.02%)
T   15.32 (+0.72%)
F   12.59 (+1.61%)
MU   68.81 (-0.52%)
CGC   0.82 (-0.62%)
GE   104.97 (-0.78%)
DIS   90.33 (-0.48%)
AMC   4.63 (+1.76%)
PFE   38.60 (+0.63%)
PYPL   64.37 (+0.64%)
NFLX   404.29 (+0.95%)
S&P 500   4,291.03 (+0.20%)
DOW   33,764.31 (+0.00%)
QQQ   356.11 (+0.41%)
AAPL   183.28 (+1.29%)
MSFT   335.54 (+0.04%)
META   271.50 (-0.41%)
GOOGL   126.07 (+1.12%)
AMZN   124.27 (+0.02%)
TSLA   219.33 (+2.51%)
NVDA   391.00 (-0.58%)
NIO   7.73 (+2.25%)
BABA   83.89 (-0.45%)
AMD   117.84 (-0.02%)
T   15.32 (+0.72%)
F   12.59 (+1.61%)
MU   68.81 (-0.52%)
CGC   0.82 (-0.62%)
GE   104.97 (-0.78%)
DIS   90.33 (-0.48%)
AMC   4.63 (+1.76%)
PFE   38.60 (+0.63%)
PYPL   64.37 (+0.64%)
NFLX   404.29 (+0.95%)
NASDAQ:KLDO

Kaleido Biosciences (KLDO) News Today

$0.0001
+0.00 (+∞)
(As of 05/23/2023)
Compare
Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.00
$0.14
Volume
775 shs
Average Volume
10,597 shs
Market Capitalization
$4,262.30
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Kaleido Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.



KLDO Media Mentions By Week

KLDO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KLDO
News Sentiment

0.88

0.56

Average
Medical
News Sentiment

KLDO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KLDO Articles
This Week

1

0

KLDO Articles
Average Week

SourceHeadline
benzinga.com logoKaleido Creative Studio Launches OnNiche™: A Niche-Based Marketing System for Financial Advisors
benzinga.com - June 3 at 2:59 PM
finanznachrichten.de logoKALEIDO INTELLIGENCE LIMITED: Kaleido Intelligence Expects 848 Million Telematics and Infotainment Cellular Subscriptions to be Active by 2028
finanznachrichten.de - April 26 at 8:48 AM
tmcnet.com logoKaleido Intelligence Expects 848 Million Telematics and Infotainment Cellular Subscriptions to be Active by 2028
tmcnet.com - April 26 at 8:48 AM
marketwatch.com logoConsumer & IoT Mobile Roaming Data Traffic Expected to Triple 2019 Volume, Approaching 3,000 Petabytes in 2023: Kaleido Intelligence
marketwatch.com - March 28 at 2:52 PM
yahoo.com logoDirect-To-Satellite Communications to Generate $9 Billion in Airtime Revenues for Operators in 2030: Kaleido Intelligence
yahoo.com - February 22 at 10:27 AM
yahoo.com logoKaleido will compensate all fraudulent withdrawals from its clients' accounts
yahoo.com - January 27 at 9:48 PM
seekingalpha.com logoKLDO Kaleido Biosciences, Inc.
seekingalpha.com - December 17 at 12:07 PM
technews.tmcnet.com logoVoLTE Roaming Readiness Ranked As High Priority For Mobile Operators: Kaleido Q3 2022 Mno Survey
technews.tmcnet.com - November 10 at 5:31 AM
tmcnet.com logoSyniverse Earns Industry Honors in Roaming and Data & Financial Clearing from Kaleido Intelligence
tmcnet.com - September 27 at 1:18 PM
benzinga.com logoAirlinq, Tata Communications and Giesecke+Devrient, Recognised as Champion Cellular IoT Connectivity Vendors by Kaleido Intelligence
benzinga.com - September 12 at 8:53 AM
benzinga.com logoExclusive Free Roaming Insights Available as Kaleido Becomes GSMA Member
benzinga.com - September 5 at 7:23 AM
yahoo.com logoIPX Networks to Carry 1,900 Petabytes of Consumer & IoT Roaming Data Traffic in 2022: Kaleido Intelligence
yahoo.com - August 23 at 5:47 PM
apnews.com logoBCE To Provide $5 Billion Operator Revenue Opportunity From Permanently Roaming IoT Devices Over the Next 5 Years: Kaleido Intelligence
apnews.com - July 26 at 8:31 AM
msn.com logoEthereum’s Kaleido Collaborates With Polygon for Web3 Adoption
msn.com - July 21 at 10:40 AM
morningstar.com logoKaleido Biosciences Inc - Stock Price vs Fair Value KLDO
morningstar.com - June 14 at 10:06 PM
tmcnet.com logoSecurity and Design are the biggest knots to untangle, according to the largest-ever IoT connectivity survey run by Kaleido Intelligence
tmcnet.com - June 7 at 6:33 PM
uk.finance.yahoo.com logoKaleido Biosciences, Inc. (KLDO)
uk.finance.yahoo.com - May 16 at 8:38 PM
seekingalpha.com logoATER, HNRG and AGLE among mid-day movers
seekingalpha.com - April 15 at 1:46 AM
benzinga.com logoKaleido Biosciences Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Kaleido Biosciences, Inc.
benzinga.com - April 11 at 7:47 PM
benzinga.com logoKaleido Biosciences Shares Halted On Code News Pending
benzinga.com - April 8 at 11:39 PM
finance.yahoo.com logoKaleido Biosciences Shares Plunging To 52-Week Low, Read Why
finance.yahoo.com - April 8 at 6:39 PM
msn.com logoFlagship’s Kaleido Biosciences shuts down, as more biotechs lay off staff
msn.com - April 8 at 1:39 PM
seekingalpha.com logoKaleido Biosciences to delist from Nasdaq as business operations end
seekingalpha.com - April 8 at 1:39 PM
bizjournals.com logoKaleido Biosciences shuts down
bizjournals.com - April 8 at 1:39 PM
marketbeat.com logo
marketbeat.com - April 8 at 10:21 AM
marketbeat.com logo
marketbeat.com - April 8 at 10:06 AM
marketbeat.com logo
marketbeat.com - April 8 at 10:06 AM
marketbeat.com logo
marketbeat.com - April 8 at 9:22 AM
finance.yahoo.com logoNovartis (NVS) Beovu Gets Label Expansion for DME in EU
finance.yahoo.com - April 1 at 11:12 AM
finance.yahoo.com logoDare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 31 at 3:10 PM
finance.yahoo.com logoBristol Myers (BMY) Gains 16% YTD: Will the Momentum Continue?
finance.yahoo.com - March 25 at 4:29 PM
finance.yahoo.com logoRezolute (RZLT) Posts Positive Data From Congenital HI Study
finance.yahoo.com - March 24 at 4:10 PM
finance.yahoo.com logoRadius Health Announces Leadership Appointments
finance.yahoo.com - March 16 at 8:58 AM
finance.yahoo.com logoAnaptysBio's (ANAB) Acne Study on Imsidolimab Fails to Meet Goal
finance.yahoo.com - March 15 at 12:51 PM
finance.yahoo.com logoAcadia (ACAD) Q4 Earnings & Revenues Fall Shy of Estimates
finance.yahoo.com - March 1 at 5:37 PM
finance.yahoo.com logoGlobal Blood's (GBT) Q4 Earnings Miss Mark, Revenues Rise Y/Y
finance.yahoo.com - February 24 at 2:33 PM
finance.yahoo.com logoKaleido Biosciences, Inc. (KLDO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
finance.yahoo.com - February 24 at 9:22 AM
finance.yahoo.com logoHere's Why Kaleido Biosciences, Inc. (KLDO) is Poised for a Turnaround After Losing 33.2% in 4 Weeks
finance.yahoo.com - February 4 at 1:52 PM
bizjournals.com logoFlagship startup cuts staff, COPD program
bizjournals.com - January 31 at 12:35 PM
finance.yahoo.com logoKaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
finance.yahoo.com - January 31 at 12:35 PM
marketbeat.com logoKaleido Biosciences (NASDAQ:KLDO) Price Target Lowered to $3.00 at Chardan Capital
marketbeat.com - January 31 at 10:30 AM
seekingalpha.com logoKaleido Bio discontinues Phase 2 KB109 study, ends collaboration with COPD Foundation
seekingalpha.com - January 31 at 2:23 AM
stockhouse.com logoKaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn's and Colitis Congress
stockhouse.com - January 23 at 10:29 PM
finance.yahoo.com logoKaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis Congress
finance.yahoo.com - January 21 at 11:56 AM
marketbeat.com logoKaleido Biosciences (NASDAQ:KLDO) Downgraded by Zacks Investment Research
marketbeat.com - January 18 at 2:29 AM
finance.yahoo.com logoKaleido Biosciences, Inc. (KLDO) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - January 5 at 1:55 PM
marketbeat.com logoKaleido Biosciences (NASDAQ:KLDO) Upgraded at Zacks Investment Research
marketbeat.com - January 5 at 8:49 AM
nasdaq.com logoKaleido Biosciences Inc Shares Close the Day 13.0% Higher - Daily Wrap
nasdaq.com - January 4 at 9:40 AM
nasdaq.com logoKaleido Biosciences Inc Shares Fall 1.2% Below Previous 52-Week Low - Market Mover
nasdaq.com - December 30 at 8:29 AM
finance.yahoo.com logoKaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions
finance.yahoo.com - December 6 at 7:43 AM
Get Kaleido Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:KLDO) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -